Sort   by:  
 Page size 
UnknownLow level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer.
Not available
S-EPMC9092774 | biostudies-literature
UnknownTacrolimus Dose Requirement in <i>De Novo</i> Adult Kidney Transplant Patients Treated With Adoport<sup>®</sup> Can Be Anticipated.
Not available
S-EPMC11513580 | biostudies-literature
UnknownDruggable <i>Nucleolin</i> Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes.
Not available
S-EPMC6210205 | biostudies-literature
UnknownPALLIA-10, a screening tool to identify patients needing palliative care referral in comprehensive cancer centers: A prospective multicentric study (PREPA-10).
Not available
S-EPMC6558580 | biostudies-literature
UnknownNISCAHN: a phase II trial of nivolumab in patients with salivary gland carcinoma (Unicancer ORL-08).
Not available
S-EPMC11235021 | biostudies-literature
UnknownLong-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study.
Not available
S-EPMC9954606 | biostudies-literature
UnknownAlterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial.
Not available
S-EPMC9604780 | biostudies-literature
UnknownTherapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network.
Not available
S-EPMC8773830 | biostudies-literature
UnknownMetastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME).
Not available
S-EPMC8327489 | biostudies-literature
Sort   by:  
 Page size